Emergent Biosolutions Inc. Withdraws FDA Approval of NARCAN Nasal Spray Supplemental New Drug Application

Summary

The FDA is withdrawing the approval of a supplemental new drug application for NARCAN nasal spray, 2 milligrams per 0.1 milliliter, after Emergent Biosolutions Inc. notified the agency that the product is not being marketed and requested withdrawal of the approval.